Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Change in Inventory: 2022-2024

Historic Change in Inventory for Amylyx Pharmaceuticals (AMLX) over the last 3 years, with Dec 2024 value amounting to $9.3 million.

  • Amylyx Pharmaceuticals' Change in Inventory fell 30.44% to $9.3 million in Q1 2024 from the same period last year, while for Mar 2024 it was $69.1 million, marking a year-over-year change of. This contributed to the annual value of $9.3 million for FY2024, which is 87.35% down from last year.
  • Per Amylyx Pharmaceuticals' latest filing, its Change in Inventory stood at $9.3 million for FY2024, which was down 87.35% from $73.1 million recorded in FY2023.
  • In the past 5 years, Amylyx Pharmaceuticals' Change in Inventory registered a high of $73.1 million during FY2023, and its lowest value of $9.3 million during FY2024.
  • For the 3-year period, Amylyx Pharmaceuticals' Change in Inventory averaged around $30.7 million, with its median value being $9.8 million (2022).
  • In the last 5 years, Amylyx Pharmaceuticals' Change in Inventory surged by 648.58% in 2023 and then plummeted by 87.35% in 2024.
  • Over the past 3 years, Amylyx Pharmaceuticals' Change in Inventory (Yearly) stood at $9.8 million in 2022, then soared by 648.58% to $73.1 million in 2023, then slumped by 87.35% to $9.3 million in 2024.